Contractor
NOMOCAN PHARMACEUTICALS LLC
NEW YORK, NY
- UEI
- H9T8M7ZBYAR8
- Parent UEI
- H9T8M7ZBYAR8
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$499,1661
Awards
1
Agencies served
1
Active from Sep 15, 2025 to Sep 1, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N91025C00050 PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION. | Department of Health and Human Services | NY | Sep 15, 2025 | $499,166 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier H9T8M7ZBYAR8, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 12, 2026.